Cancer Therapy China

China has quickly become a place of cancer expertise as many of its hospitals and research facilities open up to the world to share their industry-leading research. Cancer Bio Master as a leading cancer biotherapy organization, we collaborate with top cancer research institutes around the world including Stanford University, Wake Forest University from United States; University of Gothenburg from Sweden. We also establish many state of the art research faculties working together with hospitals in Mainland China.

Exclusive International dealer for Joinstar antigen test kitsJoinStar CE mark, EU market, registered Italy, Malaysia, Ca...
14/01/2022

Exclusive International dealer for Joinstar antigen test kits
JoinStar CE mark, EU market, registered Italy, Malaysia, Cambodia, India, Angola, Germany, France, Philippines, Brazil, Chile, Ecuador

MOQ 100k

Our manufacturer will organize local logistics. Depending on volume, small orders ship UPS/FedEx - large orders TBD

OEM/ODM accepted

Terms: PO - PI - Pay 100% - Ship - Delivery 3-7 days.

To secure your stock of Joinstar please whatsapp
https://wa.me/85297006711 or Inbox

An Amazing Life-A biography of our friend our patient how he ended up in Beijing and how he outlived the 5 years surviva...
01/02/2016

An Amazing Life-

A biography of our friend our patient how he ended up in Beijing and how he outlived the 5 years survival rate after diagnosed with stage IV colon cancer.

http://www.cancerbiomaster.com/images/stinger/An%20Amazing%20Life-a%20Biography-Sept%202015.pdf

In recent years, the treatment of patients with advanced cancer often ignore the overall situation and the patient's blo...
08/01/2016

In recent years, the treatment of patients with advanced cancer often ignore the overall situation and the patient's blood test indicators, blindly excessive of surgery, chemotherapy, radiotherapy, blindly pursuit of the eradication of the tumor in an attempt to achieve the purpose of full recovery. But because the body condition of advanced cancer patients are poor, excessive surgery and chemotherapy may cause severe damage of body immune system, create an environment for regeneration cancer, and accelerated the patients down side condition.

Status: advanced cancer treatment errors - over-treatment, damage caused by recurrent cancer immunity hasten death.
Examples of anti-cancer experts say, some patients with inoperable liver cancer, and in the use of the most powerful chemotherapy drugs for 10 days, although white blood cell decreased, the tumor was gone, but it won’t last long, the patient was soon died, autopsy found liver cancer patients is at least 3 times the original.
Large number of clinical practice has proved that for advanced cancer patients with high dose radiotherapy, chemotherapy, or drugs resistant to chemotherapy again only lead to weakening body immune system and cause of death.

1, Treatment focus of advanced stage: Controlling the tumor to achieve long-term survival rate, "Live with cancer."
Experts pointed out that the anti-cancer, advanced cancer treatment cannot pursue tumor regression, but to focus on the controlling of tumor and prolong survival of patients, in order to make happen that patients achieve long-term survival rate as to exercise "live with cancer", and "peacefully to coexist with tumor." Therefore, the most fundamental of the treatment of advanced cancer is to improve the immune system from the start, enhance immune function, and improve the body's cancer-fighting ability.

2, Immunotherapy is "live with cancer" best choice.
The body's immune function works the same as a barrier to resist the invasion of foreign innovators. If immunity is stronger than cancer, cancer will hide in the body, and if cancer is stronger than the body's immune system it will lead the growth of cancer cells.
Our immune system is the natural nemesis of cancer cells, with our own immune cells to cure our own disease, as the immune cells killing and defeating the cancer cells, it also provide recovery of healthy cells and enhance immune function, it can effectively reduce the chance of recurrence and metastasis, improving the quality of life and prolong survival, in order to achieve "green anti-cancer treatment."

In 2011, Nobel Prize in Medicine was awarded to 3 outstanding scientists in the field of the immune system. This shows that the use of immune therapy against cancer envisage a reality, a great contribution in the treatment of cancer which also received world recognition, for the majority of cancer patients lit the light of life

1, Precise killing cancer cells with non-invasive, non-toxic side effects
Immunotherapy cells are extracted immune cells in a patient, the tumor cells acquire the ability to identify a group of strong inhibitory cells cultured in the laboratory. It is absolutely non-invasive in the human body, painless, without damaging the function of the immune system to kill tumor cells but also accurately to eliminate residual of cancer tissue, with absolutely no toxic side effects, 100% of not hurting any normal cells, and so far It has not been found with any adverse reactions.

2, Improving the immune system to enhance the body's immune function effectively prevent recurrence
Immune cells can trace, identify, specifically to remove residual tumor after chemotherapy cells, restore, and recreate a healthy environment normal body needs to live, to protect the body's immune function, and sequentially improve immunity, and ultimately prohibiting tumor metastasis and recurrence, prolong the life span and improve quality of living standard of patients.

3, In-patient treatment is not a must, patients can enjoy a normal life
Immunotherapy cells generally do not need hospitalization. Immunotherapy, first step is to extract peripheral blood from patients of 50 to 100 ml, and then cultured immune cells in a laboratory with GMP standard. During cell culture, patients need not hospitalized, can go home to resume with normal life, and so when cells were cultured to a certain quantity and quality of immune cells, patient will visit the hospital for transfusion.

18/12/2015

PD-1 / PD-L1 immune cell therapy

Jimmy Carter served in 1977-1981 between the 39th President of the United States, 2002 Nobel Peace Prize, now 91-year-old announced that it has been determined, diagnosed suffering from advanced melanoma, four blocks of the brain tumor. August 20, 2015, talking about the Carter Center in Atlanta, Georgia, held a news conference terminally ill, President Carter seemed optimistic and calm, he jokingly said: "I think that the survival time of only a few weeks, but I now surprisingly relaxed, ready to meet the new adventure! "President Carter announced that it would reduce the workload, to focus on treatment. He also disclosed that his treatment options include radiation therapy and immune targeted anti-cancer drug KEYTRUDA®

KEYTRUDA® (pembrolizumab) developed by the American Merck Sharp & Dohme (MerckCo) companies. September 4, 2014, the US Food and Drug Administration (FDA) licensed for the treatment of accelerated approval Keytruda no longer respond to other advanced or unresectable melanoma. Keytruda is called PD-1 pathway blocked drug cells in the United States the first drug to be approved.

PD-1 / PD-L1 immunotherapy (immunotherapy) is currently the world's high-profile, widely studied a new class of anti-cancer immunotherapy, designed to take full advantage of the body's own immune system to resist, to fight cancer by blocking PD -1 / PD-L1 cells causing their death signaling pathway, has the potential to treat many types of cancer, is expected to substantially improve patients' overall survival. Merck, Bristol-Myers Squibb, AstraZeneca, Roche. Melanoma is the first choice to be concerned about indications. Bristol-Myers Squibb of PD-1 inhibitors Opdivo (nivolumab) in July 2014 to obtain approval in Japan to become the world's first approval of PD-1 inhibitor; and Merck Keytruda in early September 2014 approved by the FDA, is US approval of the first PD-1 inhibitors. AstraZeneca and Roche PD-L1 inhibitor also in Phase III clinical. PD-1 / PD-L1 immunotherapy may be used to a wider range of other tumors, such as lung cancer. Clinical trials monotherapy and combination therapy in full swing, to thoroughly explore the clinical potential and maximum value of such miraculous drugs.

Principle: dependent person's own immune system to fight cancer
Drug effects: through the "release of immune response" against cancer
By taking a drug isolated from a cancer patient the T cells in vitro, using genetic engineering to transform
b After the transformation of T cells that specifically recognize cancer cells and activated T cells, and then transferred back to the patient after amplification
After transformation c T cells can quickly sniff out cancer cells where they are apprehended to be processed
In simple terms, is separated from the body of the T cells in cancer patients, the use of genetic engineering in vitro transformation after transformation, T cells can specifically recognize cancer cells and activated T cells, and then transferred back to the patient after amplification.
Immunotherapy is a complement or strengthen the body's immune system in vitro original way, so that the immune system is strong enough to kill tumor cells

New York City Roswell Park Cancer Institute of Oncology, Associate Professor Grace said that the recent progress made in the immunotherapy has changed the treatment of melanoma. "10 years ago, 20 years ago, we only know how to use chemotherapy, but we know that it is not how good effect in the treatment of melanoma."

"Science" magazine editor Tim said: "Cancer immunotherapy has broad prospects are not so far wrong, that use the immune system to attack the tumor's policy is only valid for certain types of cancer and a number of patients, so it is important. point is not to exaggerate their immediate benefit. "Compared to directly attack the tumor, cancer immunotherapy is to activate the immune system to fight cancer.

PD-L1 Potential cancer immunotherapy biomarker
30/10/2015

PD-L1 Potential cancer immunotherapy biomarker

Life Story of our patient SheltonShelton is an American, he was diagnosed with cancer for over 5 years, and he is curren...
16/09/2015

Life Story of our patient Shelton

Shelton is an American, he was diagnosed with cancer for over 5 years, and he is currently working and living in Beijing. Faced with severe illness, Shelton not only changed his attitude to life, but also facing the pressure of the cost of treatment. Without the support of insurance, the cost of treatment can be a serious burden to any middle-class Americans, he also felt difficult to keep up with the treatment......

Shelton is an engineer from California, and has served as a visiting professor at Beijing University of Technology. He lives with his wife Patty in a district of Chaoyang District, Beijing, and accompany them is lovely puppy called Osito.

Shelton will be 55 years old next month. However, the last 5 years with five years of his life was totally different from what he has been living for the last 50 years, because in April 2010, he was diagnosed with colon cancer with liver metastases. So far, he spent the first 1000 days to fight with cancer, and continues to fight with cancer for the next 1,000 days, although there is a big uncertainty, surely he is facing it with positive mindset.

On his blog on April 21, 2015, he wrote "Today I celebrate my 5th anniversary while I am one of the cancer survivors at stage 4, with the same disease most people can only live for two years, but the doctor told that I have now became one of that lucky 5%. I have gone through 55 chemotherapy treatments and 3 surgeries, at the same time, I continued to work and operate business. I will continue to spend every day with appreciation. "

In January 2011, the very first surgery for Shelton was performed with intestinal and liver resection to remove any visible tumor. After the chemotherapy, he came to China, continued to work and had another phase of chemotherapy treatment. However, at this time, he found himself encountered with some the difficulties. The American insurance that he had can only cover his overseas emergency expenses, but not included the cost of conventional treatment, for which the medical expense that he spent in this phase was totally not reimbursable. With desperation, he can only return to the United States to continue treatment.

In January 2012, he again came to Beijing to do immunotherapy, and this time, the insurance company could only responsible for his medical expenses, and not be responsible for drug costs. On top of that Shelton had to borrow from some of his shares of business to settle the medical bill. Huge treatment costs for a few months can easily make a middle-upper class Americans found it difficult to manage.

In July 2012, the same surgery doctor gave him another liver resection because the cancer metastasis. Fortunately, his insurance company gave him a big surprise that they could resolved the problem of his medical expenses by switching his policy to an international insurance plan instead with 100% reimbursement of his medical expenses in Beijing. However, the downside is if he was returned to the United States, then it can be reimbursed with 80% instead, by doing such changing with insurance policy, he was so relieved.

Then, through the Cancer Bio Master Founder Sunny referral, Shelton was admitted to Beijing United Family Hospital for further treatment. Coincidentally, Shelton’s doctor and his wife turned out to be alumni, both graduated from the same university. Shelton was able to be reimbursed for the full cost of treatment for a year with over RMB $1Millon. However, just after that, the insurance company informed him that he could not continue to use such insurance scheme, which Shelton treatment plan was facing another challenge.

With this change, Shelton doctor had to adjust the chemotherapy treatment program, replacing a drug that is less expensive, and give him up to a 40% discount, so the treatment can be continued.
Currently, Shelton is working really hard on negotiating with his insurance companies to continue to cover his treatment bills in Beijing, but the outcome is not unpredictable. If this issue is not resolved, returning to the States would be the only choice.
Shelton asked his doctor how much longer he can live, this question is not easy to answer.

"I work and live in China now; I do not want to return to the States. If more than a year of my life, then I can accept myself returning to the States for this treatment as a whole purpose, otherwise, I would rather stay in China ", Shelton made it sounds like very easy. He hoped that the rest of their lives could spend in China, returning to the States is their last resort.

Shelton was never refrain from discussing the disease, he said, this cancer changed his life, making his last 5 years becoming very different as compared to his first 50 years of life. "Positive and negative, optimistic and pessimistic, always choose, and I choose to be positive and optimistic."

Shelton said: We are all the same; I want to do more within the limited time because I can barely see the end, maybe a few months, maybe a year later, and I have to leave.

Shelton also come up with a print version of the booklet, AN AMAZING LIFE written on the cover, which he summed up his first 50 years of life, the life after he was diagnosed with this disease, the American company that he worked for, and every detail since he came to China, According to book, Shelton first came to China in 2009, for the wind power projects in western China. And he came to China again came after he was diagnosed with cancer, he and his wife toured the almost the entire northwest China, Tibet, Guilin, Shaolin Temple and so many attractions, these are all written in his book.

Why did you choose China? Shelton said, "In China, I can do a lot more interesting things, travelling, learning Chinese, meeting new friends and like-minded partners. I'm just a person among few billion out there, but everyone can have some impact in the world. "He is now considering the matter after the death of his own, he is willing to discuss with someone else's life has been difficult, and to disseminate ideas to generate new idea, in order to achieve of helping others. Even though one day if he was gone, can still affect the world.

Speaking of family, Shelton said, "Everyone has their own life; we should learn to identify things from the bright side, even if only a little. I myself am so, I tell my children as well." He had 4 sons and 1 daughter, in which 3 of the children were adopted; in addition, he has 3 grandchildren. His oldest kid misses him so much; Shelton hopes the lives of children can go on smoothly.

Speaking of his wife, Shelton looked at Patty with a smile. He said the children were young, family conflicts always exist, because adopted children have behavioral problems, family relations were once very tense. However, since his illness, his relationship with his wife has unprecedented intimacy again. He hopes that Patty's life can go on smoothly.

When Patty comes to her husband's illness, attitude is very peaceful, looks calm, but the sound like it has a hidden sense. She said that if Shelton left, her life will be a big problem; she may want to go back to the States, to live with her daughter and granddaughter. "I am 52 years old, although no longer young, but not old, I do not want him to go, but anyway I have to go on living." She said.

During the conversation, Osito has been well behaved; he was always wagging his tail happily, sniffing people feet, and climbing up and down making sure you are noticed with his friendly attitude, looking at you with a pair of black eyes. This reminds me of Shelton and Patty posted a note on their front door saying:

"Welcome to our home
May God bless all who come in
God bless, we have a very special dog
He is a blind dog named Osito
Because of his blindness, when you go in, he always bark
His perception of others is by sniffing their feet
If you are not comfortable, please be sure to let us know
Bless you"

15/07/2015

If you are only left with so much time. This is how the kids would like to do.
Love your life!!

Easiest way to understand how immunotherapy may affect the PD-L1/PD-1 pathway, enabling the body to better detect and fi...
22/06/2015

Easiest way to understand how immunotherapy may affect the PD-L1/PD-1 pathway, enabling the body to better detect and fight cancer by Dr. Dan Chen.

Dr. Dan Chen explains how immunotherapy may affect the PD-L1/PD-1 pathway, enabling the body to better detect and fight cancer.

24/09/2014

What is biological therapy?

Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells. These types of biological therapy, which are sometimes referred to collectively as “immunotherapy” or “biological response modifier therapy,” do not target cancer cells directly. Other biological therapies, such as antibodies or segments of genetic material (RNA or DNA), do target cancer cells directly. Biological therapies that interfere with specific molecules involved in tumor growth and progression are also referred to as targeted therapies.

For patients with cancer, biological therapies may be used to treat the cancer itself or the side effects of other cancer treatments.

What is the immune system and what role does it have in biological therapy for cancer?

The immune system is a complex network of organs, tissues, and specialized cells. It recognizes and destroys foreign invaders, such as bacteria or viruses, as well as some damaged, diseased, or abnormal cells in the body, including cancer cells. An immune response is triggered when the immune system encounters a substance, called an antigen, it recognizes as “foreign.”

White blood cells are the primary players in immune system responses. Some white blood cells, including macrophages and natural killer cells, patrol the body, seeking out foreign invaders and diseased, damaged, or dead cells. These white blood cells provide a general—or nonspecific—level of immune protection.

Other white blood cells, including cytotoxic T cells and B cells, act against specific targets. Cytotoxic T cells release chemicals that can directly destroy microbes or abnormal cells. B cells make antibodies that latch onto foreign intruders or abnormal cells and tag them for destruction by another component of the immune system. Still other white blood cells, including dendritic cells, play supporting roles to ensure that cytotoxic T cells and B cells do their jobs effectively.

It is generally believed that the immune system’s natural capacity to detect and destroy abnormal cells prevents the development of many cancers. Nevertheless, some cancer cells are able to evade detection by using one or more strategies. For example, cancer cells can undergo genetic changes that lead to the loss of cancer-associated antigens, making them less “visible” to the immune system. They may also use several different mechanisms to suppress immune responses or to avoid being killed by cytotoxic T cells.

NAME: Ms Du ZhonghuaAGE: 54COUNTRY: ChinaDIAGNOSIS: Non-Hodgkin's lymphomaREASON FOR TREATMENT:Reoccurring of swollen ne...
04/03/2014

NAME: Ms Du Zhonghua

AGE: 54

COUNTRY: China

DIAGNOSIS: Non-Hodgkin's lymphoma

REASON FOR TREATMENT:
Reoccurring of swollen neck lump after 8 cycles of chemo, which patient cannot tolerate with the side effects of chemo

TREATMENT:
8 cycles of chemo, 1 cycle of antilogous blood CIK, 4 cycles of CIK

In 2007 August, Ms. Du was found with a swollen on the neck, and groin lump which affected walking capability, went to China Medical University Cancer Hospital, diagnosed with non-Hodgkin's lymphoma, it was at her age 47. And, her daughter was a sophomore in college at her 20. It was shocking news to her family.

In Sept 2007 started with 8 cycles of chemo treatments, however, the side effect of chemo was causing her substantial pain, including hair losses, often vomiting, lost of appetite, weight loss, immune cells strength dropped with recurring ulcers and pruritus.
After the 8 cycles of chemotherapy, swollen on neck was reduced, index resume to normal levels. And, oncologist suggested a follow-up chemo in 12 months later, Ms. Du refused due to the intolerable side effects, instead, she went on alternative traditional Chinese medicine to keep her condition steady.

In late year 2010, due to increased size of the swollen lump, Ms. Du decided that she can’t wait no more but to seek for other noninvasive treatment, CIK immunotherapy, soon after the first autologous blood CIK treatment, most of the cancer index returned to normal level, with the obvious reduced in size of neck lump, to a barely visible level. With the follow up of 4 cycles of CIK in 2 years. She was recommended to change treatment of every once a year only. In the early 2014, Ms. Du was recommended by oncologist to undergo with cord blood CIK every other 12 months.

With the combine of autologous blood and cord blood of CIK cells treatment plus the traditional Chinese medicine treatment, we can expect a very obvious result especially for non-Hodgkin's lymphoma, it can significantly decrease the size of tumor and return to a very unobvious or even normal conditions. CIK treatment is 100% green and non-invasive at all, 70% of patients might feel fatigue and lethargy, after intravenous injection. 30% might feel excited and energetic. Overall status depends on the patient's immune system, cell therapy program and frequency, as well as the patient's own condition.

Ms. Du Zhonghua is in an optimistic condition, and she just turned to be a grand-mom. And, she just celebrated for 7th birthday after she was diagnosis with non-Hodgkin's lymphoma.

Ms. Du all the best and good health.

High-Intensity Focused Ultrasound (HIFU, or sometimes FUS for Focused UltraSound) is a highly precise medical procedure ...
18/02/2014

High-Intensity Focused Ultrasound (HIFU, or sometimes FUS for Focused UltraSound) is a highly precise medical procedure that applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation.

High Intensity Focused Ultrasound (HIFU) treatment makes a use of ultrasound which is at high intensity and ultrasound beam is being focused at a specific target area to destroy cells.

The principle of how HIFU works is very much similar to how sunlight penetrating through a magnifying glass at its focus point, which is capable of burning a dry leaf.

In the case of medical surgery, the ultrasound waves are directed from a transducer (device that converts electrical energy into ultrasound energy) into a small tight focal volume. During treatment, the ultrasound beam energy penetrates though the soft tissue harmlessly except at the focal volume which cook the cells, cause coagulative necrosis and thus irreversible cell damage.

In the case of cancer treatment, each focused ultrasound beam exposure can be used to cause damage to the cancer cell in a small area and thus multiple exposures of ultrasound are needed to treat the entire tumor cells (accumulation of cancer cells).

Currently, MRgHIFU is an approved therapeutic procedure to treat uterine fibroids in Asia and the United States. USgHIFU is approved for use in China, Hong Kong, Japan, Korea, Malaysia, and the United Kingdom.

NAME:  Ms. Yan GuohuaAGE:  53COUNTRY:  Taiyuan, Shanxi Province, ChinaDIAGNOSIS:  Advance Stage Lung CancerREASONS FOR T...
28/11/2013

NAME: Ms. Yan Guohua

AGE: 53

COUNTRY: Taiyuan, Shanxi Province, China

DIAGNOSIS: Advance Stage Lung Cancer

REASONS FOR TREATMENT

After 4 cycles of chemotherapy, patient cannot tolerate with the side effects. And, refused for further chemo treatment.


TREATMENT: 4 cycles of chemo, ACTL Targeting Therapy Treatment

In June 2012, Ms.Yan Guohua, chairman of a construction company in Taiyuan, was having severe cough and went for a check-up at Shanxi local hospital with no other diagnosis, yet, cough symptoms continue. 6 months later, coughing was found more severe she then came to Beijing Cancer Hospital and diagnosis with bronchoscope, mining cell microscopic examination and found with tumor cells, went for CT and found lung metastases, pleural effusion, lymph nodes and bone metastases. Not recommended for any surgery.

She was then transferred The Armed Police General Hospital International Ward for immunotherapy in Aug 2013. Due to poor physical condition of her, blood test values were lower than normal, a cord blood CIK treatment was given, an assessment was done 2 weeks after, and found all immune cell values were back to normal range.

In September 2013, patient decided to begin with ACTL treatment which lasts 3 months. Treatment programs was a 6 times reinfusion from cultivation with peripheral blood collected from patient at 100ml each, and the other three was cultivated with peripheral blood from her son. She is currently continuing with the treatment.
Patients feedback was she is well improved with fatigue, dehydration, skin itchiness, bone aching, coughing, yet, chest pain with breathing is continued. She has received 2 times reinfusion so far, and 4 more to go.

Address

Beijing

Website

http://www.CancerBioMaster.com/

Alerts

Be the first to know and let us send you an email when Cancer Therapy China posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram